Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
Updated:4 years ago
Updated:4 years ago
Paris (France), June 19 (ANI): Dr Krishna M Ella, Chairman and Managing Director of Bharat Biotech on June 18 (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCGI) next month. “We've completed a clinical trial, data analysis is going on. We'll submit the data to regulatory agency. If everything is okay, we'll get permission to launch and it will be world's first clinically proven nasal COVID-19 vaccine,” said Dr Krishna M Ella. On the booster dose of COVID-19, Krishna said that those who had taken the second dose must take the booster dose.
Updated:2 years, 5 months ago
Amid dry winter in Kashmir, snow-clad Bangus Valley in Kupwara district emerges as winter wonderland
Updated:2 years, 5 months ago
Grand welcome given to sculptor Arun Yogiraj at Bengaluru Airport
Updated:2 years, 5 months ago
Injured WB CM Mamata Banerjee meets West Bengal Governor CV Anand Bose
Updated:2 years, 5 months ago
Couple set goals! Husband to lead Sikh Regiment, wife to command ICG contingent in R-Day Parade
Updated:2 years, 5 months ago
Inside India’s and Air India’s first Airbus A350 with luxurious seats, new interiors
Updated:2 years, 5 months ago
J-K: Srinagar’s Ghanta Ghar comes alive with spectacular Tricolour lighting